FDA wants more data on Shire's ADHD drug

... British drug maker Shire Plc said Friday the U.S. Food and Drug Administration has sought additional data as condition for approval of its drug Vyvanse, used in the treatment of Attention Deficit Hyperactivity Disorder (ADHD). Shire has developed the drug in collaboration with its U.S. partner New River Pharmaceuticals Inc. ...